KMT2A and acute lymphoblastic leukemia: Based on more recently published data, adult ALL patients can be separated in three different prognostic groups according to specific cytogenetic and molecular aberrations found at onset of disease: a standard, an intermediate, and an high-risk group, including t(4;11)(q21;q23)/MLL-AF4 positive patients (Table 2).